BioLineRx(BLRX)

财报披露

BioLineRx(BLRX)05-06 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-28 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-24 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-18 05:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-30 19:25

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接查看全文

Linktu2021-02-12 04:36

$BioLineRx(BLRX)$
该公司的牵头计划Motixafortide（BL-8040）是一种癌症治疗平台，目前正在与MSD合作的一项2a期临床试验中评估其与KEYTRUDA®和化学疗法联合治疗胰腺癌。
Motixafortide还在用于自体骨髓移植的干细胞动员的3期研究，r / r AML的2期研究以及针对急性呼吸窘迫综...查看全文

挟韭菜以令诸国2021-02-08 23:48

$BioLineRx(BLRX)$ 冲！！查看全文

Linktu2021-02-04 01:17

$BioLineRx(BLRX)$ 卖了换钱入口袋先，嘿嘿查看全文

Linktu2021-02-04 00:03

$BioLineRx(BLRX)$ 呵呵，31 号就说了强力买进，现在买进持有三天就获利不少了，加油💪查看全文

圆滚滚呀2021-02-03 23:16

$BioLineRx(BLRX)$ 又卖飞了一只，好在昨天换的另一只也在涨。查看全文

挟韭菜以令诸国2021-02-03 23:09

$BioLineRx(BLRX)$查看全文

圆滚滚呀2021-02-03 04:07

$BioLineRx(BLRX)$ 没有量根本涨不起来查看全文

圆滚滚呀2021-02-03 02:27

$BioLineRx(BLRX)$ 大中单都在流入，暂时不卖了查看全文

Linktu2021-02-02 23:38

$BioLineRx(BLRX)$ 31号才推荐买就升了,呵呵查看全文

吴多良2021-02-01 19:18

$BioLineRx(BLRX)$ 观察查看全文

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001347  Act: 34  Size: 612 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001285  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001174  Act: 34  Size: 1 MB 网页链接

招股说明书

$BioLineRx(BLRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001173  Act: 33  Size: 733 KB 网页链接

年度财报「修正」

$BioLineRx(BLRX)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001095  Act: 34  Size: 14 MB 网页链接